Trump’s FDA nominee faces Senate questions after agency layoffs and resignations
President Donald Trump’s pick to lead the Food and Drug Administration is set to answer Senate questions Thursday about his plans for the agency, which may soon be at the center of an administration ...
Key takeaways from Marty Makary’s FDA confirmation hearing
Marty Makary, a career surgeon and President Trump’s nominee to run the Food and Drug Administration (FDA), faced senators in ...
Health News Florida3h
5 takeaways from the confirmation hearing for Trump's FDA nominee
Dr. Marty Makary, President Trump's pick to run the Food and Drug Administration, faced questions from the Senate HELP ...
Trump's FDA nominee tepidly backs role for vaccine advisers in guarded Senate appearance
Martin Makary, President Donald Trump's nominee to run the U.S. FDA, told lawmakers on Thursday he would convene a committee ...
Pharmabiz3d
DCC asks expert committee to relook at guidelines for uniform implementation of powers of drug inspectors
Gireesh Babu, New Delhi Monday, March 3, 2025, 08:00 Hrs [IST] ...
The Daily Star5d
SI assaulted at Patenga beach for stopping drug use, 2 held
Two individuals were detained on charges of assaulting a police officer at Chattogram's Patenga Sea Beach for "barring a ...
JD Supra14d
OIG Deems Free Drug Patient Assistance Program Low-Risk in Advisory Opinion 25-01
On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a ...
The Hindu14d
Aurobindo Pharma arm’s New Jersey warehouse gets OAI status after U.S. FDA inspection
The U.S. Food and Drug Administration (U.S. FDA) has classified a warehouse of Aurobindo Pharma subsidiary in New Jersey, U.S. as Official Action Indicated (OAI) after an inspection it conducted.
Indiatimes14d
Orchid Pharma shares in focus as U.S. FDA completes facility inspection
Orchid Pharma share price: Orchid Pharma's Alathur facility is the only U.S. FDA-approved manufacturing site in India ... The company has successfully completed a USFDA inspection at its Active ...
Pharmabiz14d
Orchid Pharma's Alathur API facility successfully completes US FDA inspection
announced the successful completion of a surprise US Food and Drug Administration (FDA) inspection at its active pharmaceutical ingredient (API) manufacturing facility in Alathur, Tamil Nadu. The ...
Business Insider14d
FDA posts observations from AstraZeneca site inspection
The FDA posted to its site the observations made during an inspection of an AstraZeneca (AZN) manufacturing center that was conducted from May 30, 2024 to June 7, 2024, including manufacturing and ...
FiercePharma14d
FDA hits pair of Indian API makers with warning letters, import alerts
The company also was cited for refusing entry to FDA inspectors on March 15, 2024. The agency’s team was eventually granted permission to enter the facility on March 20, however, inspectors said ...